User profiles for T. Shigematsu

TOMOYOSHI SHIGEMATSU

- Verified email at mountsinai.org - Cited by 2920

Takashi Shigematsu

- Verified email at sis.seirei.or.jp - Cited by 555

A new classification of diabetic nephropathy 2014: a report from joint committee on diabetic nephropathy

…, S Ogawa, M Inaba, Y Kanno, T Shigematsu… - Clinical and …, 2015 - Springer
… ; Yoshihiko Kanno has received scholarship grants from pharmaceutical company Chugai
Pharmaceutical Co., Ltd., travel expenses from Abbott Japan Co., Ltd.; Takashi Shigematsu

Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency

T Shigematsu, JJ Kazama, T Yamashita… - American Journal of …, 2004 - Elsevier
Background: Fibroblast growth factor 23 (FGF-23) is a recently identified polypeptide that
promotes renal phosphate excretion and decreases serum 1,25-dihydroxyvitamin D 3 (1,25D) …

Effect of dilution rate on structure of a mesophilic acetate-degrading methanogenic community during continuous cultivation

T Shigematsu, Y Tang, H Kawaguchi… - Journal of Bioscience …, 2003 - Elsevier
The community structures of two mesophilic acetate-degrading methanogenic consortia
enriched at dilution rates of 0.025 and 0.6 d −1 were analyzed by fluorescence in situ …

An overview of regular dialysis treatment in Japan (as of 31 December 2010)

…, T Shigematsu, T Shinoda, T Shoji… - Therapeutic …, 2012 - Wiley Online Library
A nationwide statistical survey of 4226 dialysis facilities was conducted at the end of 2010,
and 4166 facilities (98.6%) responded. The number of new patients introduced into dialysis …

Large-vessel stroke as a presenting feature of Covid-19 in the young

…, IP Singh, RA De Leacy, T Shigematsu… - … England Journal of …, 2020 - Mass Medical Soc
Stroke in Young Patients with Covid-19 Five patients younger than 50 years of age with
large-vessel stroke and Covid-19 infection presented to a health system in New York City over a …

[PDF][PDF] Clinical practice guideline for the management of chronic kidney disease‐mineral and bone disorder

…, M Hattori, A Ashida, K Iseki, T Shigematsu… - … Apheresis and Dialysis, 2013 - jsdt.or.jp
… ,1 Takatoshi Kakuta,1 Hideki Fujii,1 Msasaaki Nakayama,1 Yugo Shibagaki,1 Seiji Fukumoto,2
Naohiko Fujii,1 Motoshi Hattori,1 Akira Ashida,1 Kunitoshi Iseki,1 Takashi Shigematsu,1 …

Delftia tsuruhatensis sp. nov., a terephthalate-assimilating bacterium isolated from activated sludge

T Shigematsu, K Yumihara, Y Ueda… - … of systematic and …, 2003 - microbiologyresearch.org
… A phylogenetic study based on 16S rRNA gene sequences indicated that strain T7 T should
… T7 T and Delftia acidovorans ATCC 15668 T . Major cellular fatty acids of strain T7 T were C…

[HTML][HTML] Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients

…, T Yamashita, S Fukumoto, F Gejyo, T Shigematsu… - Kidney international, 2005 - Elsevier
… Paired t tests were applied to compare each area under curve (AUC) obtained by ROC.
The computations were carried out on an Apple Macintosh computer type G4 with StatView …

Numerical modeling of the initial stages of dam-break waves

T Shigematsu, PLF Liu, K Oda - Journal of Hydraulic Research, 2004 - Taylor & Francis
In this paper, we present a numerical investigation of dam-break waves during the initial
stage. The numerical model is based on the Reynolds Averaged Navier-Stokes (RANS) …

Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure

JJ Kazama, T Shigematsu, K Yano, E Tsuda… - American journal of …, 2002 - Elsevier
Skeletal resistance to parathyroid hormone (PTH) is one of the major abnormalities underlying
bone diseases in uremia, the mechanism of which has not yet been fully elucidated. …